Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical atorvastatin, licorice + aloe vera, and clobetasol for psoriasis
IRCT20240220061059N10Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atorvastatin, glycyrrhiza glabra, aloe vera and clobetasol in psoriasis (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Psoriasis Area Severity Index. Started May 2026; status: completed.
02
Drugs
atorvastatinglycyrrhiza glabraaloe veraclobetasol
03
Conditions
psoriasis
Beyond the preview
Go deeper on IRCT20240220061059N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240220061059N10.